Pradaxa Oral Pellets — Medical Mutual
Deep Vein Thrombosis or Pulmonary Embolism, To Reduce the Risk of Recurrence
Initial criteria
- Patient is age ≥ 8 years
Reauthorization criteria
- Continuation requires response to therapy unless otherwise noted
Approval duration
1 year